Alterations in FLT3 have also been found in colon adenocarcinoma, lung adenocarcinoma, and invasive ductal breast cancer and to a lesser extent other solid tumors, notably melanoma (11.04%), colorectal cancer (7.91%), endometrial cancer (7.68%), non-small cell lung carcinoma (4.18%), sarcoma (3.92%) and other cancer types in the cancer genome atlas (TCGA) database as analyzed on cbioportal [11,12,13]. This evidence concerns the gene FLT3 and cancer.